Summary: The Beckley Foundation and ICEERS are investigating the long-term effects of treating anxiety, depression, and posttraumatic stress disorder (PTSD) with ayahuasca. Researcher Debora Gonzalez, Ph.D., will present the study results at Psychedelic Science 2017. “We’re asking whether ayahuasca is an effective tool to support emotional regulation in people suffering from anxiety, depression, post-traumatic stress disorder (PTSD) and grief,” explains Gonzalez.
Originally appearing here.
Psychedelic Science 2017 will be a crossroads where the paths of contemporary science and ancient healing wisdom intersect. From the apex of this cultural reconciliation, Débora González, Ph.D, will present the preliminary findings from a collaborative study by the Beckley Foundation and ICEERS, investigating the long-term effects of ayahuasca on mental health and quality of life in Western users.
“We’re asking whether ayahuasca is an effective tool to support emotional regulation in people suffering from anxiety, depression, post-traumatic stress disorder (PTSD) and grief,” she explains.
About the research
The Beckley/ICEERS research project was conducted at the Temple of the Way of Light, an ayahuasca retreat in the Peruvian Amazon where ceremonies are led by Onanya (healers) of the Shipibo tribe.
In the months leading up to their treatment, participants underwent a series of tests designed to analyze their psychopathology levels and overall quality of life. These tests were then repeated immediately after the ayahuasca workshops and again three months later, with plans to conduct further analyses after six and twelve months.
“Results so far have been striking,” says González. “Over the course of a retreat – which can range from nine days to three weeks and involve five to eight ayahuasca sessions – we see a reduction in psychopathological symptoms that lasts for three months. We’re yet to conduct the six-month follow-up analysis so I can’t say if this will continue, but it’s clear that the effect is persistent.”
Interestingly, while improvements were seen in patients with all four emotional disorders, those with PTSD appeared to experience the most benefit. “When we compare quality of life scores before and after ayahuasca treatment, we see that the biggest improvement is in those with PTSD.”
How does ayahuasca produce these effects?
“Psychedelics allow access to layers of experience that are beyond the reach of regular therapies,” explains González. Therefore, rather than directing patients towards confronting the specific traumatic events underlying their condition – as is the common protocol for treating PTSD – ayahuasca allows users to relive the raw emotions behind their trauma, such as fear and helplessness. In doing so, it facilitates a reconnection with one’s former victimised self and provides an opportunity to heal by nourishing one’s self with love and compassion, finally meeting the emotional needs that for so long had gone unfilled.
Through ayahuasca, patients were able to liberate themselves from their long-standing pain, and thereafter began to exhibit higher scores for several core traits associated with mindfulness. In particular, we saw an increase in ‘decentering’, which refers to the ability to calmly observe one’s thoughts and feelings, detaching them from one’s own sense of identity in order to become less judgemental towards them and more self-accepting.
What risks does ayahuasca pose?
The International Narcotics Control Board (INCB) has recently published two reports urging governments to crack down on ayahuasca over fears that its use – particularly among Westerners – could have negative health effects. In particular, the reports express concern that taking ayahuasca outside of its traditional cultural context could lead to substance abuse disorders as people become hooked on it or use it as a gateway to other drugs.
Yet no scientific evidence currently exists to either support or refute these claims, so the Beckley/ICEERS team analysed the substance use patterns of all participants both before and after their ayahuasca treatments.
Based on the established criteria for diagnosing mental illnesses set out by the American Psychiatric Association, the researchers found no evidence of any patients developing substance abuse disorders, either in relation to ayahuasca itself or other drugs.
Overall, the researchers conclude that ayahuasca does promote emotional regulation in sufferers of depression, anxiety, PTSD and grief. Moreover, its use breathes new life into modern psychotherapy by opening up alternative paths towards healing – including those first paved by the Shipibo ancestors.